Aura Biosciences, Inc. - Common Stock, par value $0.00001 per share (AURA)

Q: What does CUSIP 05153U107 represent in this 13F holders report?

CUSIP 05153U107 is the security identifier for AURA - Aura Biosciences, Inc. - Common Stock, par value $0.00001 per share used to aggregate holder disclosures.

Q: How many institutions held AURA - Aura Biosciences, Inc. - Common Stock, par value $0.00001 per share in Q2 2026?

146 institutional investors reported AURA - Aura Biosciences, Inc. - Common Stock, par value $0.00001 per share for Q2 2026. Use the holders table for investor-level position and value details.

CUSIP: 05153U107

Q2 2026 13F Holders as of 30 Jun 2026

Security type / class: Equity / Common Stock, par value $0.00001 per share
Total 13F shares: 95,385,877
Total 13F value: $677,249,273
Share change: +41,992,987
Put/Call ratio: 1014%
SEC-reported price per share: $7.10
Number of holders: 146
Value change: +$301,096,905
Number of buys: 92
Number of sells: 41
Shares outstanding: 102,550,724

Security key

05153U107

Report period

Q2 2026

Institutions

146

Top holders

AURA full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2026 Previous quarter: Q4 2025 Aura Biosciences, Inc. SEC filings Aura Biosciences, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 05153U107

Newer quarter: Q3 2026 Previous quarter: Q4 2025

Recent filing periods:

Q3 2026 Q4 2025 Q3 2025

Ownership snapshot

Top reported holders of AURA - Aura Biosciences, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

TCG Crossover GP II, LLC

Disclosed value leader

Adage Capital Management,...

Comparable rows

5/15

Latest evidence

30 Jun 2026

13D/G 13F 3/4/5 Lead comparable stake: 9.9% 10 rows are not safely comparable across share classes. 13D/G row: TCG Crossover GP II, LLC Showing 1-6 of 15 holder rows.

Quick read

TCG Crossover GP II, LLC leads the comparable SEC ownership view at 9.9%.

5 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens TCG Crossover GP II, LLC's linked filing trail.

Comparable ownership Top 5

TCG Crossover GP II, LLC 9.9%

Adage Capital Management, L.P. 8.4%

Frazier Life Sciences Public Fund... 5.6%

Long Focus Capital Management, LLC 4.9%

Advent Life Sciences LLP 3.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
TCG Crossover GP II, LLC	13D/G Chen Yu 13D/G	9.9% Reported 13D/G · 05 May 2026	$64,540,664 9,533,333 shares	$0	05 May 2026
Adage Capital Management, L.P.	13D/G 13D/G	8.4% Reported 13D/G · 30 Jun 2026	$64,640,487 9,104,294 shares	$0	30 Jun 2026
Frazier Life Sciences Public Fund, L.P.	13D/G 13D/G	5.6% Reported 13D/G · 30 Jun 2026	$41,231,546 5,807,260 shares	+$12,603,920	30 Jun 2026
Long Focus Capital Management, LLC	13D/G 13F Company 13D/G 13F	4.9% Reported 13D/G · 30 Jun 2026	$36,349,032 5,119,582 shares	+$12,780,000	30 Jun 2026
Advent Life Sciences LLP	13D/G Rajesh Parekh, Ph.D. 13D/G	3.3% Reported 13D/G · 13 Feb 2026	$11,768,148 2,071,857 shares	$0	13 Feb 2026
Matrix Capital Management Company, LP	3/4/5 13F 10%+ Owner · Company 3/4/5 13F	— denominator unverified	$62,305,830 6,922,870 shares	-$39,044,987	07 May 2026

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

146

95,385,877

Rows available

146

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q4 2025 Across Filers

Q4 2025 holders

116

Q2 2026 holders

146

Holder diff

Investor	Q4 2025 Shares	Q2 2026 Shares	Share Diff	Share Chg %	Q4 2025 value	Q2 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend